Thomas S. Mir

Plasma Concentrations of N-Terminal Pro-Brain Natriuretic Peptide in Control Children From the Neonatal to Adolescent Period and in Children With Congestive Heart Failure

Thomas S. Mir, Sönke Marohn, Stephanie Läer et al. · PEDIATRICS · 2002 · 175 citations

Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth

Thomas S. Mir, Reinhard Laux, Hans Henning Hellwege et al. · PEDIATRICS · 2003 · 144 citations

Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters

Stephanie Läer, Thomas S. Mir, Frederike Behn et al. · American Heart Journal · 2002 · 143 citations

Heart Failure, Carvedilol Therapy, Cardiorenal Syndromes +9

Frequency and Age-Related Course of Mitral Valve Dysfunction in the Marfan Syndrome

Meike Rybczynski, Thomas S. Mir, Sara Sheikhzadeh et al. · The American Journal of Cardiology · 2010 · 90 citations

Marfan Syndrome, Heart Failure, Age-related Course +5

N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability

Stefanie Albers, Thomas S. Mir, Munif Haddad et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2005 · 87 citations

Normal Ranges, Inter-laboratory Variability, Method Comparison +15